Endocrinology, Vol 125, 2935-2944, Copyright © 1989 by Endocrine Society

ARTICLES

Signalling elements in the ultradian rhythm of circulating growth hormone regulating expression of sex-dependent forms of hepatic cytochrome P450

BH Shapiro, JN MacLeod, NA Pampori, JJ Morrissey, DP Lapenson and DJ Waxman
Laboratories of Biochemistry, University of Pennsylvania School of Veterinary Medicine, Philadelphia 19104-6048.

Neonatal male rats were treated with monosodium glutamate (MSG) at either 2 or 4 mg/g BW on alternate days during the first 10 days of life. As adults, the 4 mg MSG-treated rats displayed the obesity, growth retardation, and reduced pituitary weights that typify this syndrome. These animals had no detectable plasma GH as determined from serial blood samples taken every 20 min for 8 consecutive h. Associated with this loss of circulating GH was an induction of the female- specific hepatic cytochrome P450 2d (gene IIC12) and the disappearance of the male-specific form of cytochrome P450 2c (gene IIC11). The catalytic activities of cytochrome P450 2c (i.e. androgen 16 alpha- and 2 alpha-hydroxylase), sex-dependent hexobarbital hydroxylase and total cytochrome P450 were similarly feminized. Rats exposed to the 2-mg dose of MSG were also obese, but their growth rates and pituitary sizes were not as severely affected as in the 4 mg MSG-treated rats. Circulating GH in these lower dosed males was secreted in a pulsatile pattern similar to that in normal males, except that the pulse amplitude was reduced as much as 90%. In spite of this profound decline in GH peak heights in the 2 mg MSG-treated males, liver metabolism was characteristically masculine. That is, female-specific cytochrome P450 2d remained undetectable, while the male forms of cytochrome P450 2c, 2a (gene IIIA2), and RLM2 (gene IIA2), their respective catalytic steroid hydroxylase activities, and associated sex-dependent drug- metabolizing enzymes were expressed at the level of or greater than that in normal males. Thus, while an ultradian pulse of circulating GH is necessary for the characteristically masculine profile of sex- specific forms of hepatic cytochrome P450, neither the amplitude of the secretory peaks nor their total GH content is critical, and these can be greatly reduced from the normal male levels.

This article has been cited by other articles:

				R. N. Dhir, C. Thangavel, and B. H. Shapiro Attenuated Expression of Episodic Growth Hormone-Induced CYP2C11 in Female Rats Associated with Suboptimal Activation of the Jak2/Stat5B and Other Modulating Signaling Pathways Drug Metab. Dispos., November 1, 2007; 35(11): 2102 - 2110. [Abstract] [Full Text] [PDF]

				A. S. Verma, R. N. Dhir, and B. H. Shapiro Inadequacy of the Janus Kinase 2/Signal Transducer and Activator of Transcription Signal Transduction Pathway to Mediate Episodic Growth Hormone-Dependent Regulation of Hepatic CYP2C11 Mol. Pharmacol., March 1, 2005; 67(3): 891 - 901. [Abstract] [Full Text] [PDF]

				R. N. Dhir and B. H. Shapiro Interpulse growth hormone secretion in the episodic plasma profile causes the sex reversal of cytochrome P450s in senescent male rats PNAS, December 9, 2003; 100(25): 15224 - 15228. [Abstract] [Full Text] [PDF]

				M. R. Sharma, P. Periandythevar, and B. H. Shapiro SPURIOUS OBSERVATION OF SPLENIC CYP2B1 EXPRESSION Drug Metab. Dispos., September 1, 2003; 31(9): 1074 - 1076. [Abstract] [Full Text] [PDF]

				C. J. Henderson, D. M. E. Otto, D. Carrie, M. A. Magnuson, A. W. McLaren, I. Rosewell, and C. R. Wolf Inactivation of the Hepatic Cytochrome P450 System by Conditional Deletion of Hepatic Cytochrome P450 Reductase J. Biol. Chem., April 4, 2003; 278(15): 13480 - 13486. [Abstract] [Full Text] [PDF]

				A. Kaufhold, P. K. Nigam, R. N. Dhir, and B. H. Shapiro Prevention of Latently Expressed CYP2C11, CYP3A2, and Growth Hormone Defects in Neonatally Monosodium Glutamate-Treated Male Rats by the N-Methyl-D-Aspartate Receptor Antagonist Dizocilpine Maleate J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 490 - 496. [Abstract] [Full Text] [PDF]

				R. N. Dhir, W. Dworakowski, and B. H. Shapiro Middle-Age Alterations in the Sexually Dimorphic Plasma Growth Hormone Profiles: Involvement of Growth Hormone-Releasing Factor and Effects on Cytochrome P450 Expression Drug Metab. Dispos., February 1, 2002; 30(2): 141 - 147. [Abstract] [Full Text] [PDF]

				N. A. Pampori, A. K. Agrawal, and B. H. Shapiro Infusion of Gender-Dependent Plasma Growth Hormone Profiles Into Intact Rats: Effects of Subcutaneous, Intraperitoneal, and Intravenous Routes of Rat and Human Growth Hormone on Endogenous Circulating Growth Hormone Profiles and Expression of Sexually Dimorphic Hepatic Cyp Isoforms Drug Metab. Dispos., January 1, 2001; 29(1): 8 - 16. [Abstract] [Full Text]

				N. A. Pampori and B. H. Shapiro Nominal Growth Hormone Pulses in Otherwise Normal Masculine Plasma Profiles Induce Intron Retention of Overexpressed Hepatic CYP2C11 with Associated Nuclear Splicing Deficiency Endocrinology, November 1, 2000; 141(11): 4100 - 4106. [Abstract] [Full Text] [PDF]

				D. M. Keenan and J. D. Veldhuis Explicating hypergonadotropism in postmenopausal women: a statistical model Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2000; 278(5): R1247 - R1257. [Abstract] [Full Text] [PDF]

				A. K. Agrawal and B. H. Shapiro Differential Expression of Gender-Dependent Hepatic Isoforms of Cytochrome P-450 by Pulse Signals in the Circulating Masculine Episodic Growth Hormone Profile of the Rat J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 228 - 237. [Abstract] [Full Text]

				M. Kawai, S. M. Bandiera, T. K. H. Chang, F. M. Poulet, P. M. Vancutsem, and G. D. Bellward Modulation of Hepatic CYP2A1, CYP2C11, and CYP3A9 Expression in Adult Rats by Neonatal Administration of Tamoxifen Drug Metab. Dispos., December 1, 1999; 27(12): 1392 - 1398. [Abstract] [Full Text]

				J. A. Nishime, R. W. Wang, J. H. Lin, and M. Chiba Modulation of Rat Cytochrome P-450 by an Investigational HIV Protease Inhibitor Drug Metab. Dispos., September 1, 1999; 27(9): 972 - 976. [Abstract] [Full Text]

				E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF]

				N. A. Pampori and B. H. Shapiro Gender Differences in the Responsiveness of the Sex-Dependent Isoforms of Hepatic P450 to the Feminine Plasma Growth Hormone Profile Endocrinology, March 1, 1999; 140(3): 1245 - 1254. [Abstract] [Full Text]

				A. K. Agrawal and B. H. Shapiro Gender, Age and Dose Effects of Neonatally Administered Aspartate on the Sexually Dimorphic Plasma Growth Hormone Profiles Regulating Expression of the Rat Sex-Dependent Hepatic CYP Isoforms Drug Metab. Dispos., November 1, 1997; 25(11): 1249 - 1256. [Abstract] [Full Text]

				T. K. H. Chang, M. D. Anderson, S. M. Bandiera, and G. D. Bellward Effect of Ovariectomy and Androgen on Phenobarbital Induction of Hepatic CYP2B1 and CYP2B2 in Sprague-Dawley Rats Drug Metab. Dispos., August 1, 1997; 25(8): 994 - 1000. [Abstract] [Full Text]